Abstract: The present invention describes pyridazinone compounds of formula (I) which are cyclooxygenase (COX) inhibitors, and in particular, are selective inhibitors of cyclooxygenase-2 (COX-2). COX-2 is the inducible isoform associated with inflammation, as opposed to the constitutive isoform, cyclooxygenase-1 (COX-1) which is an important 'housekeeping' enzyme in many tissues, including the gastrointestinal (GI) tract and the kidneys. The selectively of these compounds for COX-2 minimizes the unwanted GI and renal side-effects seen with currently marketed non-steroidal anti-inflammatory drugs (NSAIDs).
| # | Name | Date |
|---|---|---|
| 1 | IN-PCT-2001-00450-MUM-FORM 19 (17-05-2004).pdf | 2004-05-17 |
| 2 | in-pct-2001-00450-mum-form 1(17-5-2004).pdf | 2018-08-08 |
| 3 | in-pct-2001-00450-mum-correspondence(ipo)-(22-4-2010).pdf | 2018-08-08 |
| 4 | in-pct-2001-00450-mum-correspondence(10-5-2004).pdf | 2018-08-08 |
| 5 | abstract1.jpg | 2018-08-08 |